By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


Company News
Aurinia (ISA.TO) To Present At The 2016 BIO Investor Forum In San Francisco On October 18, 2016 10/11/2016 11:50:11 AM
Aurinia (ISA.TO) Releases Open-Label AURION Data Demonstrating Increased Remission Rates Over Time For Voclosporin In The Treatment Of Lupus Nephritis 10/6/2016 7:43:09 AM
Aurinia (ISA.TO) Announces That Voclosporin Achieves Primary And All Pre-Specified Secondary Endpoints In Its Phase IIb AURA-LV Study For Lupus Nephritis (LN) 9/30/2016 9:39:28 AM
Aurinia (ISA.TO) To Present At The Leerink Partners Roundtable Series In New York September 28, 2016 9/22/2016 11:11:45 AM
Aurinia (ISA.TO) To Host Lupus Nephritis (LN) Breakfast And Webcast On September 30th In New York 9/21/2016 11:15:15 AM
Aurinia (ISA.TO) To Present At The 2016 Rodman & Renshaw 18th Annual Global Investment Conference 9/7/2016 1:50:37 PM
Aurinia (ISA.TO)'s Voclosporin Meets Primary Endpoint in Phase IIB Aura-LV Study in Lupus Nephritis 8/15/2016 6:51:12 AM
Aurinia (ISA.TO) Reports Second Quarter 2016 Financial Results And Operational Highlights 8/5/2016 11:29:11 AM
Aurinia (ISA.TO) To Host Lupus Nephritis Expert Breakfast And Webcast On August 4th In New York 7/29/2016 8:41:37 AM
Aurinia (ISA.TO) Establishes At-The-Market Facility 7/25/2016 10:47:49 AM